Acadia Pharmaceuticals did not disclose the buyer of the priority review voucher. The biotech received the voucher last year alongside the regulatory decision that made its drug Daybue the first ...

Spark Therapeutics has sold a priority review voucher, entitling the holder to a faster six-month FDA drug review, to Ireland’s Jazz Pharmaceuticals for $110m, a fraction of the price these ...

Pharming has agreed a deal to sell a recently awarded priority review voucher (PRV) to Novartis for around $21 million - well below the market rate. The price of PRVs, which can be used to shorten ...

Grabowski was part of the team that originally proposed the priority-reviews vouchers idea (Health Affairs, 25, 313–324, 2006). That the idea has been translated into government action so ...

30, 2026, to receive vouchers for their qualifying drugs, after that, the FDA will no longer be allowed to give out priority review vouchers.

The VERV program is modeled after the successful Tropical Disease Priority Review Voucher Program that was legislated in 2007 at the US Food and Drug Administration (FDA). VERV is intended to ...

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the closing of the sale of its Rare Pediatric Disease Priority Review Voucher (PRV) for $150 million before fees and expenses.

Cyprium is eligible to receive royalties and will retain ownership of any priority review vouchers – a reward given to sponsors for firms that develop drugs to treat rare pediatric diseases ...

As described below, Cyprium is eligible to receive royalties and retains ownership of any Priority Review Voucher that may be issued. The CUTX-101 NDA submission is supported by positive topline ...

Shortly after, Gov. Greg Abbott reminded senators of the importance of their duties over the next 140 days, with passing a school voucher proposal still a top priority. Vouchers would allow Texas ...